.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint requires addition of people along with MASLD as well as dimension of liver end results in cardio-- renal-- metabolic tests, when data recommend mechanistically conceivable benefits as well as professional security-- and also summarizes considerations for trial style and also regulative commendation.